Ovarian Reserve and Ankylosing Spondylitis

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

December 19, 2019

Primary Completion Date

May 19, 2020

Study Completion Date

May 19, 2020

Conditions
Ovarian DiseasesAnkylosing SpondylitisAnti-Mullerian Hormone Deficiency
Interventions
OTHER

ovarian reserve for Ankylosing spondylitis and control groups

"Additional organ diseases due to the pathophysiology of the disease may be seen in women with ankylosing spondylitis. therefore, we established the first group of women with the diagnosis of ankylosing spondylitis.~Women Who Are Diagnosed With Ankylosing Spondylitis Will Form The Study Group. and health women will be control group.~Clinical And Laboratory Parameters Will Be Evaluated For Ovarian Capacity Of These Women.~Amh Will Be Looked For (Pmol / L). Antral Folukul Census In The Overin Folukular Stage Will Be Valued As Number. Fsh (Iu / L) And Estradiol (Pmol / L) Values Will Also Be Recorded."

Trial Locations (1)

33404

Kanuni Sultan Süleyman Training and Research Hospital, Istanbul

All Listed Sponsors
lead

Kanuni Sultan Suleyman Training and Research Hospital

OTHER

NCT04209881 - Ovarian Reserve and Ankylosing Spondylitis | Biotech Hunter | Biotech Hunter